Riskpilot← Back to searchSign inGet full accessBRILLERINGEN AS
ASActiveOrg 947994921Søndre Gate 18, 7011 TrondheimRetail sale of medical and orthopaedic goods · NACE 4774Est. 19886 employees
Revenue 2024
NOK 8,8M
0% vs 2023
EBITDA margin
9.9%
-26% vs 2023
Equity ratio
61.5%
Financial strength
Net profit 2024
NOK 386K
-30% vs 2023
| Revenue | NOK 8,8M | +0% |
| EBITDA | NOK 875K | -26% |
| Net profit | NOK 386K | -30% |
| Total assets | NOK 3,9M | -19% |
| Equity | NOK 2,4M | +19% |
| Employees | 6 | — |
Legal name
BRILLERINGEN AS
Org number
947994921
Legal form
Aksjeselskap
NACE code
4774 · Retail sale of medical and orthopaedic goods
Founded
7. juni 1988
Share capital
—
Employees
6 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Address
Søndre Gate 18, 7011 Trondheim
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5 754 | 5 973 | 5 329 | 6 051 | 5 686 | 6 177 | 6 122 | 6 629 | 6 369 | 6 504 | 7 145 | 7 245 | 7 447 | 7 777 | 8 381 | 8 833 | 8 807 |
| Staff expenses | −1 636 | −1 793 | −1 511 | −1 843 | −1 839 | −1 848 | −1 886 | −2 098 | −2 182 | −2 175 | −2 583 | −2 594 | −2 376 | −2 756 | −3 249 | −3 087 | −3 195 |
| EBITDA | 551 | 670 | 547 | 608 | 549 | 818 | 766 | 778 | 530 | 689 | 725 | 650 | 1 243 | 958 | 854 | 1 182 | 875 |
| Depreciation & amort. | −222 | −186 | −204 | −194 | −153 | −158 | −254 | −261 | −175 | −206 | −219 | −172 | −424 | −422 | −403 | −442 | −401 |
| EBIT | 330 | 483 | 343 | 413 | 396 | 660 | 512 | 517 | 355 | 484 | 506 | 477 | 819 | 536 | 450 | 740 | 474 |
| Net financials | −51 | −5 | −49 | −68 | −64 | −56 | −51 | −47 | −39 | −13 | −2 | −1 | −54 | −43 | −50 | −30 | 22 |
| Profit before tax | 278 | 478 | 293 | 345 | 333 | 604 | 461 | 471 | 316 | 470 | 504 | 477 | 765 | 493 | 401 | 711 | 497 |
| Tax | −3 | 45 | 30 | 26 | 21 | 101 | 125 | 136 | 84 | 119 | 121 | 105 | 170 | 109 | 88 | 157 | 110 |
| Net profit | 397 | 433 | 264 | 319 | 312 | 503 | 336 | 334 | 231 | 352 | 382 | 372 | 595 | 384 | 313 | 553 | 386 |
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 3 290 | 3 075 | 2 682 | 2 679 | 2 367 | 2 859 | 2 875 | 2 775 | 2 552 | 2 635 | 2 901 | 6 808 | 5 047 | 4 766 | 4 915 | 4 889 | 3 941 |
| Equity | 490 | 624 | 487 | 806 | 1 118 | 1 421 | 1 119 | 1 154 | 1 185 | 1 237 | 1 619 | 1 591 | 1 786 | 1 870 | 1 882 | 2 035 | 2 422 |
| Long-term debt | 899 | 656 | 414 | 172 | 0 | 355 | 565 | 445 | 319 | 186 | 48 | 2 000 | 1 823 | 1 642 | 1 470 | 1 302 | 0 |
| Short-term debt | 1 901 | 1 795 | 1 781 | 1 702 | 1 249 | 1 083 | 1 190 | 1 176 | 1 048 | 1 212 | 1 234 | 3 217 | 1 438 | 1 255 | 1 563 | 1 552 | 1 519 |
| Total debt | 2 800 | 2 451 | 2 195 | 1 873 | 1 249 | 1 438 | 1 755 | 1 621 | 1 367 | 1 398 | 1 282 | 5 217 | 3 261 | 2 896 | 3 033 | 2 854 | 1 519 |
EBITDA margin
9.9%
This company
15.8%
Market median
-37% vs market
20082024
Equity ratio
61.5%
This company
38.2%
Market median
+61% vs market
20082024
Return on equity
16.0%
This company
18.4%
Market median
+13% vs market
20082024
Net profit margin
4.4%
This company
8.1%
Market median
-46% vs market
20082024
Asset turnover
2.23×
This company
1.12×
Market median
+99% vs market
20082024
Debt / equity
0.63×
This company
0.62×
Market median
+2% vs market
20082024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2011-01-01 – 2011-12-31
- Annual report 2010Filed via Brønnøysundsregistrene · Period 2010-01-01 – 2010-12-31
- Annual report 2009Filed via Brønnøysundsregistrene · Period 2009-01-01 – 2009-12-31
- Annual report 2008Filed via Brønnøysundsregistrene · Period 2008-01-01 – 2008-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2016 | — | — | |
| Board of Directors | 2025 | — | — | |
| Chairman | 2025 | — | — | |
| Board of Directors | 2016 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Gobiss As | Company | 66.0% | 66.0% | 2024 |
Juma Holding As | Company | 34.0% | 34.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Mas Invest As
BRILLERINGEN AS Board members of BRILLERINGEN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Birger Magne Sæther | Chairman | 0 companies |
| Trond Lie Jensen | Board of Directors | 0 companies |
| Kjetil Engen | Chairman | 0 companies |
| Klaus Arne Sjøhaug | Board of Directors | 0 companies |